Clinical Trial Update: Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib to prevent head and neck cancer in patients with oral leukoplakia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Leukoplakia

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Head and Neck Cancer, Precancerous Condition | Phase 2 | Status: COMPLETED